NCT03811613View on ClinicalTrials.gov

Photobiomodulation and Parkinson

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

January 29, 2018

Primary Completion Date

March 30, 2018

Study Completion Date

March 30, 2018

Conditions
Parkinson Disease
Interventions
OTHER

Transcranial photobiomodulation

Photobiomodulation was administered using red light-emitting diodes (LEDs) with a 670-nm wavelength (which has proven to penetrate the skull)

Trial Locations (2)

24071

Department of Physical Education and Sport, University of León, León

33005

University School of Sports Medicine, University of Oviedo, Spain., Oviedo

All Listed Sponsors
lead

University of Oviedo

OTHER

NCT03811613 - Photobiomodulation and Parkinson | Biotech Hunter | Biotech Hunter